BioLife Solutions (STU:BJX1) Total Liabilities : €39.33 Mil (As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is BioLife Solutions Total Liabilities?

BioLife Solutions's Total Liabilities for the quarter that ended in Mar. 2025 was €39.33 Mil.

BioLife Solutions's quarterly Total Liabilities declined from Sep. 2024 (€50.63 Mil) to Dec. 2024 (€48.30 Mil) and declined from Dec. 2024 (€48.30 Mil) to Mar. 2025 (€39.33 Mil).

BioLife Solutions's annual Total Liabilities declined from Dec. 2022 (€81.22 Mil) to Dec. 2023 (€68.82 Mil) and declined from Dec. 2023 (€68.82 Mil) to Dec. 2024 (€48.30 Mil).

BioLife Solutions Total Liabilities Historical Data

The historical data trend for BioLife Solutions's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioLife Solutions Total Liabilities Chart

BioLife Solutions Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

24.32

67.47

81.22

68.82

48.30

BioLife Solutions Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Liabilities	Get a 7-Day Free Trial															62.74	49.73	50.63	48.30	39.33

BioLife Solutions Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

BioLife Solutions's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	31.261	+	(16.923	+	2.1094237467878E-15
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0.118	+	0	+	0)
	=	48.30

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	381.51	-	333.208
	=	48.30

BioLife Solutions's Total Liabilities for the quarter that ended in Mar. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	25.644	+	(13.564	+	4.5519144009631E-15
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0.12	+	0	+	0)
	=	39.33

Total Liabilities	=	Total Assets (Q: Mar. 2025 )	-	Total Equity (Q: Mar. 2025 )
	=	365.505	-	326.177
	=	39.33

BioLife Solutions Total Liabilities Related Terms

Thank you for viewing the detailed overview of BioLife Solutions's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

BioLife Solutions Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BioLife Solutions Inc (STU:BJX1) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

BLFS:USA

Address

3303 Monte Villa Parkway, Suite 310, Bothell, WA, USA, 98021

Website

https://www.biolifesolutions.com

BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.

BioLife Solutions Headlines

No Headlines